期刊文献+

糖皮质激素受体拮抗剂的作用机制研究与相关药物开发 被引量:2

Researches on the Mechanism of Action of Glucocorticoid Receptor Antagonists and the Related Drug Development
下载PDF
导出
摘要 综述糖皮质激素受体介导的糖异生机制以及该受体激动剂和拮抗剂的作用机制,分类介绍糖皮质激素受体拮抗剂的研究与开发。早期的糖皮质激素受体拮抗剂米非司酮具有较好的活性,但同时具有抗孕激素作用,选择性差,副作用多,因此,寻找和发现高选择性的糖皮质激素受体拮抗剂已成为抗2型糖尿病药物研究的新领域。 The mechanism of glucocorticoid receptor(GR)-mediated gluconeogensis and GR agonism and antagonism was reviewed. The research and development of GR antagonists were introduced classifiedly. Early GR antagonist mifepristone shows good activity, but at the same time it has anti-progestogen activity, poorspecificity and more side effects. So screening and finding of high specific GR antagonists have become a new field of research on anti-type 2 diabetes drugs.
出处 《药学进展》 CAS 2008年第6期256-262,共7页 Progress in Pharmaceutical Sciences
关键词 糖皮质激素受体 选择性糖皮质激素受体拮抗剂 作用机制 2型糖尿病 Glucocorticoid receptor Specific GR antagonist Mechanism of action Type 2 diabetes
  • 相关文献

参考文献22

  • 1Abate N, Chandalia M. The impact of ettmieity on type 2 diabetes [ J ]. J Diabetes Complications, 2003, 17 ( 1 ) : 39-58.
  • 2Yoon J C, Puigserver P, Chen G X, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 [ J]. Nature,2001,413(6852) :131-138.
  • 3Kleiman A, Tuckermann J P. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice [ J ]. Mol Cell Endocrinol,2007,275 (1-2) :98-108.
  • 4Kumar R, Thompson E B. Gene regulation by the glucocorticoid receptor: Structure: function relationship [ J ]. J Steroid Biochem Mol Biol,2005,94 (5) :383-394.
  • 5Bledsoe R K, Montana V G, Stanley T B, et al. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition [ J ]. Cell ,2002,110 ( 1 ) :93-105.
  • 6MeGrane M M, Yun J S, Moorman A F, et al. Melabolie effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice [ J ]. J Biol Chem, 1990,265 (36) :22371-22379.
  • 7Vegiopoulos A, Herzig S. Glucocorticoids, metabolism and metabolic diseases [ J ]. Mol Cell Endocrinol, 2007,275 (1-2) :43451.
  • 8Kauppi B, Jakob C, Famegardh M, et al. The three-dimensional structures of antagonistic and agonistic forms of the glueocortieoid receptor ligand-binding domain[ J]. J Biol Chem,2003,278 (25) : 22748 -22754.
  • 9Schulz M, Eggert M, Baniahmad A, et al. RU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and corepressor binding[ J]. J Biol Chem, 2002,277 (29) :26238-26243.
  • 10Wang Z, Frederick J, Garabedian M J. Deciphering the phosphorylation "Code" of the glucocorticoid receptor in vivo[ J ]. J Biol Chem,2002,277 (29) :26573-26580.

同被引文献33

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部